X0202 3 2007-05-11 0 0001066833 DOV PHARMACEUTICAL INC DOVP 0000919185 HIGHBRIDGE CAPITAL MANAGEMENT LLC 9 WEST 57TH STREET 27TH FLOOR NEW YORK NY 10019 0 0 1 0 0001308315 Highbridge International LLC THE CAYMAN CORPORATE CENTRE, 4TH FLOOR 27 HOSPITAL ROAD GEORGE TOWN, CAYMAN ISLANDS E9 BWI CAYMAN ISLANDS 0 0 1 0 0001308597 Dubin Glenn C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC 9 WEST 57TH STREET, 27TH FLOOR NEW YORK NY 10019 0 0 1 0 0001308598 Swieca Henry C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC 9 WEST 57TH STREET, 27TH FLOOR NEW YORK NY 10019 0 0 1 0 Series C Convertible Preferred Stock 2007-05-11 shares of common stock, par value $0.0001 per share 13295418 I See footnotes The Series C Convertible Preferred Stock is convertible into common stock at a conversion rate of 191.02612143 shares of common stock for one share of Series C Convertible Preferred Stock and shall be automatically converted to common stock on June 11, 2007 at the same conversion ratio. 13,295,418 shares of Common Stock are issuable to Highbridge International LLC upon conversion of the Series C Convertible Preferred Stock. Highbridge Capital Management, LLC is the trading manager of Highbridge International LLC. Glenn Dubin is a Co-Chief Executive Officer of Highbridge Capital Management, LLC. Henry Swieca is a Co-Chief Executive Officer of Highbridge Capital Management, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock owned by another Reporting Person to the extent such beneficial ownership exceeds such Reporting Person's pecuniary interest. HIGHBRIDGE CAPITAL MANAGEMENT, LLC, By: /s/ Carolyn Rubin, Managing Director 2007-06-08